loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Sodium Picosulfate

    Menu

    Sodium Picosulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 405Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 202535 / DOSAGE - FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ANHYDROUS CITRIC ACID(UNII: XF417D3PSL)
    (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL)     		ANHYDROUS CITRIC ACID12g in 16.2 | 12g in 16.1
    MAGNESIUM OXIDE(UNII: 3A3U0GI71G)
    (MAGNESIUM CATION - UNII:T6V3LHY838)     		MAGNESIUM OXIDE3.5g in 16.2 | 3.5g in 16.1
    SODIUM PICOSULFATE(UNII: LR57574HN8)
    (DEACETYLBISACODYL - UNII:R09078E41Y)     		SODIUM PICOSULFATE10mg in 16.2 | 10mg in 16.1

    Inactive Ingredients

    Ingredient Name
    Ferring Pharmaceuticals Inc.
    CRANBERRY(0MVO31Q3QS)
    ORANGE(5EVU04N5QU)
    POTASSIUM BICARBONATE(HM5Z15LEBN)
    SACCHARIN SODIUM(SB8ZUX40TY)